Get all your news in one place.
100's of premium titles.
One app.
Start reading
France 24
France 24
World
FRANCE 24

WHO launches first trial of antiviral to prevent Bundibugyo strain of Ebola

Director General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus speaks to the media regarding the epidemic of Ebola disease caused by the Bundibugyo virus.
Director General of the World Health Organization (WHO) Tedros Adhanom Ghebreyesus speaks to the media regarding the epidemic of Ebola caused by the Bundibugyo virus in the Democratic Republic of the Congo and Uganda on May 22, 2026. © Martial Trezzini, AP

The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent infection in people exposed to the Bundibugyo strain of Ebola in the Democratic Republic of Congo, as the outbreak continues to outpace response efforts and spread beyond known chains of transmission.

The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Democratic Republic of Congo, the WHO said Tuesday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.